COLLINGWOOD, Ontario, Sept. 07, 2016 -- Isowater Corporation (Isowater), a reliable supplier of deuterium oxide (heavy water) and deuterium gas systems, is pleased to announce that Dr. Joseph P. Porwoll, a former executive of Sigma-Aldrich, has been appointed to its Board of Directors.
Dr. Porwoll joined Isowater in 2014 as Vice President of Business Development after a successful 30-year career with Aldrich Chemical Company (later Sigma-Aldrich) a world leading speciality chemical company in the life science and high tech sector. During his career with Sigma-Aldrich he served in a variety of roles including President of Aldrich Corporation and Vice President of Global Supply Chain of Sigma Aldrich where he provided corporate guidance to senior leaders of various operational functions and defined crucial strategies for improvements to supply chain execution. In addition, he developed, manufactured and managed stable isotope production systems including those with deuterium. Throughout his career Dr. Porwoll has established a broad network of contacts in the high tech, life sciences and environmental sectors. Dr. Porwoll holds a Ph.D. in Bio-Organic Chemistry from the University of Minnesota, Minneapolis. In addition to his commercial expertise and contacts, Dr. Porwoll brings extensive technical knowledge of the key markets for Isowater’s deuterium products.
Since joining Isowater, Dr. Porwoll has expanded Isowater’s business activities in the US and certain international markets. Dr. Porwoll’s addition to the Board of Directors is a further demonstration of Isowater’s commitment to meeting the needs of our customers particularly in the life sciences, including the growing pharmaceutical markets.
Andrew Stuart, President & CEO of Isowater Corporation, states, "Joe brings a wealth of technical expertise to the Board, which is critical to strategic planning and setting our overall strategic direction. Isowater is responding to increased demand for its products in both traditional markets and new emerging growth markets. Joe’s experience and technical input is critical to our success to date and to future market penetration."
Upcoming Event
15th Annual Contract Pharma 2016
Isowater’s Vice President & General Manager, A. James (Jim) Farmilo, Ph.D. and Isowater’s Vice President of Sales & Marketing, Lisa A. Stuart will be attending the 15th Annual Contract Pharma 2016 Contracting & Outsourcing Conference, Sept. 22nd & 23rd Hyatt Regency, New Brunswick, New Jersey http://conference.contractpharma.com/. To coordinate a meeting with Jim or Lisa please contact us at sales @isowater.com.
About Isowater
Isowater Corporation is a Canadian clean technology company and leading global supplier of deuterium oxide and related products for the Life Sciences, High Technology and Environmental Science sectors. Our products are deuterium oxide (heavy water; 2H20; D20) and custom solutions for deuterium gas management (heavy hydrogen gas; 2H2; D2).
Applications for Isowater’s deuterium products within the Life Sciences, High Technology and Environmental Science sectors include: Pharmaceutical, Semiconductors, Fibre Optics, Health and Beauty products, Medical Procedures, Research and Hydrology.
Isowater is supplying the needs of customers for deuterium oxide today while at the same time developing supply chain solutions that lower deuterium oxide cost through recycling. Isowater’s focus is to ensure long term stable supply to meet the needs of customers.
Contact: Wanda Cutler Director of Marketing and Communications Isowater Corporation Email: [email protected] Telephone: 416-303-6460 www.isowater.com www.linkedin.com/company/1820527 www.facebook.com/isowatercorp


Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
First Western Ship Transits Strait of Hormuz Since Iran War Began
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 



